Westwood Holdings Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,133
Closed -$466K 548
2022
Q4
$466K Buy
10,133
+616
+6% +$28.8K ﹤0.01% 415
2022
Q3
$482K Sell
9,517
-443
-4% -$22.1K 0.01% 369
2022
Q2
$454K Buy
9,960
+5,337
+115% +$239K 0.01% 393
2022
Q1
$215K Buy
+4,623
New +$207K ﹤0.01% 444

Other funds holding LMAT

Westwood Holdings Group's LMAT Position: Q1 2023 in Review

Westwood Holdings Group sold out of LeMaitre Vascular (LMAT) in Q1 2023, closing a stake of 10,133 shares — an estimated $466K sold.

Westwood Holdings Group first reported a position in LMAT in Q1 2022 and held it in 4 quarters. The position peaked at $482K in Q3 2022. 184 funds tracked by Wall St. Rank hold LMAT as of Q1 2023.

  • Westwood Holdings Group reported no remaining LeMaitre Vascular position as of Q1 2023 after selling out during the quarter.
  • Westwood Holdings Group sold 10,133 LeMaitre Vascular shares in Q1 2023, an estimated $466K.
  • Westwood Holdings Group first reported a position in LeMaitre Vascular in Q1 2022 and held it in 4 quarters.
  • Westwood Holdings Group's LeMaitre Vascular position peaked at $482K in Q3 2022.
  • 184 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2023.

Based on Westwood Holdings Group's 13F filing for Q1 2023, filed 12 May 2023.